FDA Issues New GLP-1 Warning Over Potential for Catastrophic Side Effect
(KMDL-FM) Everything comes with a cost, but how does that cost compare to the benefits? When it comes to losing weight or helping control diabetes, many Americans and their doctors have chosen to walk the fine line between obesity and better health through the use of GLP-1 medicines.
What you did not bargain for was trading one medical malady for perhaps a situation that is much worse. The United States Food and Drug Administration has just updated warnings for those who use GLP-1 meds to include what can only be described as a catastrophic side effect.
All Major GLP-1 Meds Are Included In This FDA Advisory
These medicines have been proven to be highly effective in helping those with diabetes control that medical issue, but hundreds of thousands of people across the nation have lost tons and tons of weight by using these medications. They are sold under brand names like Ozempic, Wegovy, Mounjaro, and Zepbound. And while they are very effective, they, too, have side effects.
One of those potential side effects has prompted a warning from the Food and Drug Administration. has to do with a rare eye condition. The condition is described in medical books as nonarteritic anterior ischemic optic neuropathy, or NAION.
READ MORE: Certain Shipments of GLP-1 Meds Recalled - Here's Why
The condition interrupts the flow of blood to the optic nerve in the eyes. This can cause sudden, yet painless vision loss. This usually happens in one eye. Unfortunately, there is no known treatment that can reverse vision that is lost from NAION.
What Is the Likelihood of Vision Loss From Using GLP-1 Medications?
The FDA Advisory explained that the condition is rare and that the medicines have not been proven to cause the condition. The advisory was posted after new studies appeared to show a potential connection between medicines and the condition.
The connection noted in the study was a catalyst that has now prompted the FDA to require all GLP-1 medicines to carry information about the potential risk of the NAION eye condition.
READ MORE: Secret Side Effect of GLP-1 Meds That is Changing Lives
Patients should not stop taking their medication without consulting their healthcare team. However,if you do notice sudden changes in your vision with or without pain, you should contact your primary care physician, an urgent care, or emergency department.
If you have an eye care professional who monitors your eye health, contacting them would be advised as well.
10 You Gotta Try Meals in Lafayette and Acadiana - Breakfast, Lunch, Dinner, Late Night
Gallery Credit: Bruce Mikells
